Risk for arterial thromboembolic events (ates) in patients with advanced urinary tract cancer (autc) treated with first-line chemotherapy: single-center, observational study

HIGHLIGHTS

  • who: Aristotelis Bamias and collaborators from the nd Propaedeutic Internal Medicine, and Kapodistrian University Athens, ATTIKON University Hospital, Rimini, Chaidari, Attiki, Greece have published the paper: Risk for Arterial Thromboembolic Events (ATEs) in Patients with Advanced Urinary Tract Cancer (aUTC) Treated with First-Line Chemotherapy: Single-Center, Observational Study, in the Journal: (JOURNAL)

SUMMARY

    The association between cancer and clinical hypercoagulability is well-known. Risk Assessment Models (RAMs) have been developed to identify cancer patients in high risk to develop VTE and thus could be candidates for prevention strategies. Established risk factors for . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?